TerminatedNot applicableNCT06513663

Exercise as Maintenance Therapy in Advanced Lung Cancer

The purpose of this study is to examine how a multimodality (having or using a variety of methods to do something) exercise intervention may improve survival, function, and quality of life in participants with advanced lung cancer.

Checked against the public recordLast updated Apr 27, 2026 · Source: ClinicalTrials.gov

StatusTerminated
PhaseNot applicable
U.S. locations3
SponsorIndiana University
01
Study overview

What this study is about

Purpose
Supportive Care
Study type
Interventional
Phase
Not applicable
Sponsor
Indiana University
Interventions being studied
Behavioral: Exercise Intervention
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

Inclusion Criteria: 1. Age ≥ 18 years 2. Known diagnosis of locally advanced (stage III) or metastatic NSCLC 3. Patient is currently receiving maintenance immunotherapy for at least 1 month and planned for at least 3 additional months of therapy 1. Patients receiving maintenance therapy refers to patients with stable disease or partial response to therapy, including patients who have had a history of disease progression but are currently stable or responding to a different therapy 2. Patients previously receiving chemotherapy are eligible as long as at least one month has elapsed since completing chemotherapy. Those currently receiving chemotherapy are not eligible. 4. Patient is willing and able to participate in a supervised home-based exercise program as determined by the MOVE program a.Participants must have internet access and equipment to participate in virtual exercise 5. ECOG performance status of 0-2 Exclusion Criteria: 1. Already meeting exercise guidelines and participating in at least 150 minutes of moderate or vigorous exercise per IPAQ 2. Unable to participate in the supervised home-based exercise program as determined by the MOVE program 3. Medical co-morbidities that preclude patient from participating in supervised exercise, including but not limited to: * Advanced heart failure * Advanced respiratory disease requiring home oxygen use * Uncontrolled psychiatric disorders * History of fragility fracture

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Indiana University Health Methodist HospitalIndianapolis, Indiana
  • Indiana University Melvin & Bren Simon Comprehensive Cancer CenterIndianapolis, Indiana
  • Sidney and Lois Eskenazi HospitalIndianapolis, Indiana

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Apr 27, 2026. Always confirm current availability with the study team.

View original record ↗